IBD

Clinical trials for IBD explained in plain language.

Never miss a new study

Get alerted when new IBD trials appear

Sign up with your email to follow new studies for IBD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1 Terminated 1

Crohn's drug study halted early: what happened?

Disease control Terminated

This study looked at the long-term safety of brazikumab in people with moderate to severe Crohn's disease. It included 18 adults who had already been in a previous brazikumab study. The main goal was to track side effects and lab results. The study was terminated early, so result…

Matched conditions: IBD

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 15, 2026 19:02 UTC

IBD

Get alerted when new IBD trials appear

Crohn's drug study halted early: what happened?